Molecular interactions between the urokinase receptor and integrins in the vasculature

被引:10
|
作者
May, AE [1 ]
Kanse, SM [1 ]
Chavakis, T [1 ]
Preissner, KT [1 ]
机构
[1] Max Planck Inst, Kerckhoff Klin, Haemostasis Res Unit, D-61231 Bad Nauheim, Germany
来源
FIBRINOLYSIS & PROTEOLYSIS | 1998年 / 12卷 / 04期
关键词
D O I
10.1016/S0268-9499(98)80014-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell-cell and cell-ECM interactions are key events in morphogenic processes during developmental and reproductive phases, in immune defense, wound healing and tissue repair, or hemostasis. Their dysregulation plays a major role in the pathophysiology of cardiovascular diseases (atherosclerosis, restenosis, thrombosis) or angiogenesis-driven tumor progression. Protease cascades such as the plasminogen activation system are linked to cell adhesion and migration. The urokinase-type plasminogen activator (uPA) as well as its receptor (uPAR) has been found in a complex with beta(1)-, beta(2)-, and beta(3)-integrins, thereby allowing mutual interactions and regulatory processes between cell adhesion and proteolysis to occur. Moreover, both uPAR and PAI-1 are capable of binding to vitronectin, an adhesive extracellular matrix protein, that serves as ligand for vascular integrins in an RGD-dependent manner. This short review will focus on the molecular and functional interactions between the uPAR system and vascular integrins and discuss consequences for vascular cell functions.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 50 条
  • [1] Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with β1 integrins
    Tang, Chi-Hui
    Hill, Marla L.
    Brumwell, Alexis N.
    Chapman, Harold A.
    Wei, Ying
    JOURNAL OF CELL SCIENCE, 2008, 121 (22) : 3747 - 3756
  • [2] The urokinase receptor and integrins in cancer progression
    C.-H. Tang
    Y. Wei
    Cellular and Molecular Life Sciences, 2008, 65 : 1916 - 1932
  • [3] The urokinase receptor and integrins in cancer progression
    Tang, C. -H.
    Wei, Y.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (12) : 1916 - 1932
  • [4] Novel interactions between urokinase and its receptor
    Shliom, O
    Huang, M
    Sachais, B
    Kuo, A
    Weisel, JW
    Nagaswami, C
    Nassar, T
    Bdeir, K
    Hiss, E
    Gawlak, S
    Harris, S
    Mazar, A
    Higazi, AA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) : 24304 - 24312
  • [5] Protease crosstalk with integrins: The urokinase receptor paradigm
    Chapman, HA
    Wei, Y
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (01) : 124 - 129
  • [6] Mapping the interactions between urokinase plasminogen activator receptor and high molecular weight kininogen.
    Mahdi, F
    Kuo, A
    Shariat-Madar, Z
    Cines, DB
    Schmaier, AH
    BLOOD, 2002, 100 (11) : 71B - 71B
  • [7] Urokinase receptor and integrin interactions
    Kugler, MC
    Wei, Y
    Chapman, HA
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (19) : 1565 - 1574
  • [8] Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and β2-integrins
    Chavakis, T
    May, AE
    Preissner, KT
    Kanse, SM
    BLOOD, 1999, 93 (09) : 2976 - 2983
  • [9] Cleavage of urokinase receptor regulates its interaction with integrins in thyroid cells
    Montuori, N
    Rossi, G
    Ragno, P
    FEBS LETTERS, 1999, 460 (01) : 32 - 36
  • [10] Modulation of NK cell integrins by urokinase plasminogen activator receptor (uPAR)
    Gellert, GC
    Kitson, RP
    Goldfarb, RH
    FASEB JOURNAL, 2002, 16 (05): : A1212 - A1212